Resistance to anti-angiogenic therapy in pediatric solid tumors.
|
Feinstein Institute for Medical Research - North Shore / Samuel Soffer, MD |
Young Investigator Grants |
2007 |
New York |
Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma |
University of Pennsylvania / Nicole Anderson, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation |
MD Anderson Cancer Center / Yuan Pan, PhD |
Young Investigator Grants |
2020 |
Texas |
Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct |
University of Wisconsin - Madison / Mario Otto |
Young Investigator Grants |
2012 |
Wisconsin |
The Identification of Neuroblastoma Cancer Stem Cells.
|
Stanford University / Robert Cho |
Young Investigator Grants |
2007 |
California |
Novel Synergistic Targets for Combination Therapy in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Yang Ding, MD |
Young Investigator Grants |
2020 |
Pennsylvania |
Genetic Profiling and Experimental Modeling of High-risk Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Kathryn Roberts, PhD |
Young Investigator Grants |
2013 |
Tennessee |
High-Throughput Gene-Editing via Microfluidic Cell Deformability to Enable Off-the-Shelf Allogeneic Cellular Immunotherapies |
University of California, Los Angeles / Steven Jonas, MD/PhD |
Young Investigator Grants |
2017 |
California |
STING Pathway Activation: The Missing Link between Genomic Instability and Antitumor Immunity in Osteosarcoma |
University of California San Francisco / Elizabeth Young, MD |
Young Investigator Grants |
2021 |
California |
Treatment for human hepatoblastoma based on recombinant adeno-associated virus vectors |
University of Florida / Chen Ling |
Young Investigator Grants |
2012 |
Florida |